
Publications
Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Amyloid-Beta42 Aggregation in Alzheimer's Disease
Biophysical Journal
(2018)
114
225A
(doi: 10.1016/j.bpj.2017.11.1253)
Modulating Amyloid-Beta Aggregation to Reduce the Toxicity of its Oligomeric Aggregates
Biophysical Journal
(2018)
114
430a
(doi: 10.1016/j.bpj.2017.11.2382)
Probing the Interaction of ABETA42 Amyloid Species with an Aggregation Suppressor Molecule by Infrared Nanospectroscopy
Biophysical Journal
(2018)
114
224A
(doi: 10.1016/j.bpj.2017.11.1246)
Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
Proceedings of the National Academy of Sciences
(2017)
114
8005
(doi: 10.1073/pnas.1700239114)
Attenuating the Toxicity of Amyloid-Beta Aggregation with Specific Species
Biophysical Journal
(2017)
112
494a
(doi: 10.1016/j.bpj.2016.11.2673)
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
Proceedings of the National Academy of Sciences of the United States of America
(2016)
114
e200
(doi: 10.1073/pnas.1615613114)
A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
ACS Combinatorial Science
(2016)
18
144
(doi: 10.1021/acscombsci.5b00129)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease
Sci Adv
(2016)
2
e1501244
(doi: 10.1126/sciadv.1501244)
- ‹ previous
- Page 2